Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/120474
Title: Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease : a European multicentre observational cohort study
Authors: Tai, Foong Way D.
Ellul, Pierre
Elosua, Alfonso
Fernandez‐Urien, Ignacio
Tontini, Gian E.
Elli, Luca
Eliakim, Rami
Kopylov, Uri
Koo, Sara
Parker, Clare
Panter, Simon
Sidhu, Reena
McAlindon, Mark
Keywords: Inflammatory bowel diseases
Crohn's disease
Ulcerative colitis
Capsule endoscopy
Gastrointestinal system -- Examination
Patient monitoring
Issue Date: 2021
Publisher: John Wiley & Sons Ltd.
Citation: Tai, F. W. D., Ellul, P., Elosua, A., Fernandez‐Urien, I., Tontini, G. E., Elli, L., ... & McAlindon, M. (2021). Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease: a European multicentre observational cohort study. United European Gastroenterology Journal, 9(2), 248-255.
Abstract: Background: Endoscopically defined mucosal healing in Crohn's disease is associated with improved outcomes. Panenteric capsule endoscopy enables a single non‐invasive assessment of small and large bowel mucosal inflammation. Aims and Methods: This multicentre observational study of patients with suspected and established Crohn's disease examined the feasibility, safety and impact on patient outcomes of panenteric capsule endoscopy in routine clinical practice. The potential role in assessment of disease severity and extent by a comparison with existing clinical and biochemical markers is examined. Results: Panenteric capsule endoscopy was performed on 93 patients (71 with established and 22with suspected Crohn's disease). A complete examination occurred in 85% (79/93). Two cases (2.8%) of capsule retention occurred in patients with established Crohn's disease. Panenteric capsule resulted in management change in 38.7%(36/93) patients, including 64.6%(32/48) of those with an established diagnosis whose disease was active, and all three patients with newly diagnosed Crohn's disease. Montreal classification was upstaged in 33.8% of patients with established Crohn's disease and mucosal healing was demonstrated in 15.5%. Proximal small bowel disease upstaged disease in 12.7% and predicted escalation of therapy (odds ratio 40.3, 95% confidence interval 3.6–450.2). Raised C‐reactive protein and faecal calprotectin were poorly sensitive in detecting active disease (0.48 and 0.59 respectively). Conclusions: Panenteric capsule endoscopy was feasible in routine practice and the ability to detect proximal small bowel disease may allow better estimation of prognosis and guide treatment intensification. Panenteric capsule endoscopy maybe a suitable non‐invasive endoscopic investigation in determining disease activity and supporting management decisions.
URI: https://www.um.edu.mt/library/oar/handle/123456789/120474
Appears in Collections:Scholarly Works - FacM&SMed



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.